The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Bosley Katrine since year 2005.
The trader's CIK number is 1592469.
At the time of this reporting, Bosley Katrine is the President and CEO of Editas Medicine, Inc. .
(stock ticker symbol EDIT).
See this page for all insider trading activities at Editas Medicine, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-12-01||EDIT||Editas Medicine, Inc.||Sale||8,333||29.50||245,790|
|2017-11-01||EDIT||Editas Medicine, Inc.||Sale||8,333||24.22||201,858|
|2017-10-02||EDIT||Editas Medicine, Inc.||Sale||8,333||25.05||208,741|
|2017-09-05||EDIT||Editas Medicine, Inc.||Sale||6,666||20.20||134,679|
|2017-09-01||EDIT||Editas Medicine, Inc.||Sale||10,000||20.80||207,970|
|2017-08-11||EDIT||Editas Medicine, Inc.||Sale||6,666||20.02||133,453|
|2017-08-10||EDIT||Editas Medicine, Inc.||Sale||10,000||20.02||200,159|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bosley Katrine (President and CEO of Editas Medicine, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.